Ligand validation:5QCP

E4G: (4S)-4-[(1R)-1-hydroxy-2-({[3-(propan-2-yl)phenyl]methyl}amino)ethyl]-19-(2-oxopropoxy)-11,16-dioxa-3-azatricyclo[15.3.1.1~6,10~]docosa-1(21),6(22),7,9,17,19-hexaen-2-one

E4G is a Ligand Of Interest in 5QCP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QCP_E4G_C_401	66%	67%	0.138	0.944	0.66	0.61	1	1	0	0	100%	0.9405
5QCP_E4G_A_401	60%	66%	0.15	0.937	0.82	0.51	1	-	0	0	100%	0.9524
5QCP_E4G_B_401	59%	66%	0.151	0.933	0.71	0.62	1	-	0	0	100%	0.9286

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.